Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ·Healthcare·Biotechnology
$2.75
+5.57%
Mkt Cap $211.69M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$7.00
Range $5.00 – $9.00
Implied Upside
+154.5%
Consensus $7.00 vs current $2.75
NASDAQ·Healthcare·Biotechnology
$2.75
+5.57%
Mkt Cap $211.69M
No recent rating data.
Price Target (2 analysts)
$7.00
Range $5.00 – $9.00
+154.5%
Consensus $7.00 vs current $2.75